Skip to main content

All three major indices are trading down today with the

Dow Jones Industrial Average

(

^DJI

) trading down 91 points (-0.6%) at 16,239 as of Wednesday, Sept. 23, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,111 issues advancing vs. 1,847 declining with 164 unchanged.

The Financial sector currently sits down 0.1% versus the S&P 500, which is down 0.4%. On the negative front, top decliners within the sector include

Banco Santander Brasil SA/Brazil

(

BSBR

), down 3.6%,

BanColombia

(

CIB

), down 3.4%,

Grupo Financiero Santander Mexico SAB de CV

(

TheStreet Recommends

BSMX

), down 3.4%,

Credit Suisse Group

(

CS

), down 2.3% and

Blackstone Group

(

BX

), down 2.6%.

TheStreet would like to highlight 3 stocks pushing the sector higher today:

3.

BioMed Realty

(

BMR

) is one of the companies pushing the Financial sector higher today. As of noon trading, BioMed Realty is up $2.59 (13.5%) to $21.77 on heavy volume. Thus far, 5.2 million shares of BioMed Realty exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $21.04-$21.83 after having opened the day at $21.25 as compared to the previous trading day's close of $19.18.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. BioMed Realty has a market cap of $4.0 billion and is part of the real estate industry. The company has a P/E ratio of 19.7, below the S&P 500 P/E ratio of 24.8. Shares are down 11.0% year-to-date as of the close of trading on Tuesday. Currently there are 5 analysts who rate BioMed Realty a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates

BioMed Realty

as a

hold

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, reasonable valuation levels and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and a generally disappointing performance in the stock itself. Get the full

BioMed Realty Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

New York Community Bancorp

(

NYCB

) is up $0.28 (1.6%) to $17.88 on heavy volume. Thus far, 3.9 million shares of New York Community Bancorp exchanged hands as compared to its average daily volume of 3.2 million shares. The stock has ranged in price between $17.69-$18.34 after having opened the day at $17.69 as compared to the previous trading day's close of $17.60.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

New York Community Bancorp, Inc. operates as a holding company for New York Community Bank and New York Commercial Bank that offer banking products and financial services in New York, New Jersey, Florida, Ohio, and Arizona. New York Community Bancorp has a market cap of $7.9 billion and is part of the banking industry. The company has a P/E ratio of 16.0, below the S&P 500 P/E ratio of 24.8. Shares are up 10.0% year-to-date as of the close of trading on Tuesday. Currently there is 1 analyst who rates New York Community Bancorp a buy, 4 analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

New York Community Bancorp

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

New York Community Bancorp Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

MetLife

(

MET

) is up $0.12 (0.3%) to $46.32 on average volume. Thus far, 3.7 million shares of MetLife exchanged hands as compared to its average daily volume of 6.3 million shares. The stock has ranged in price between $46.20-$47.13 after having opened the day at $46.47 as compared to the previous trading day's close of $46.20.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. MetLife has a market cap of $52.4 billion and is part of the insurance industry. The company has a P/E ratio of 7.9, below the S&P 500 P/E ratio of 24.8. Shares are down 14.6% year-to-date as of the close of trading on Tuesday. Currently there are 11 analysts who rate MetLife a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates

MetLife

as a

buy

. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, notable return on equity and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

MetLife Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the financial sector could consider

Financial Select Sector SPDR

(

XLF

) while those bearish on the financial sector could consider

Proshares Short Financials

(

SEF

).